No black box warning on record for Dual Action
As of the latest FDA labeling reviewed, Dual Action (ACETAMINOPHEN AND IBUPROFEN (NSAID) TABLETS, 250 MG/ 125 MG) does not carry a black box warning. Standard warnings and precautions still apply — see the full Dual Action medicine page for the complete safety profile.